The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage (Q40073382)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

title

The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

main subject

DNA damage

0 references

author

Chandra Belani

series ordinal

5

0 references

author name string

Rentian Feng

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

Ana Oton

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

Markus Y Mapara

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

Gülsüm Anderson

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

Suzanne Lentzsch

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

published in

British Journal of Haematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

volume

139

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

page(s)

385-397

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

cites work

Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06772.X

retrieved

21 January 2018

Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06772.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2141.2007.06772.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

PubMed publication ID

17910628

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17910628

retrieved

17 September 2017

ResearchGate publication ID

5933656

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40073382&oldid=1883655808"